RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders
RAE(实现、分析、参与)——一种基于数字生物标记的检测和干预系统,用于治疗药物滥用疾病恢复过程中的压力和渴望
基本信息
- 批准号:9545385
- 负责人:
- 金额:$ 22.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-15 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAlcohol or Other Drugs useAlgorithmsAnxietyAwardBehaviorBehavior TherapyBiological MarkersBiosensorBusinessesCar PhoneCaringClinicalDataDetectionDevicesDiseaseDrug usageEngineeringEnvironmentEventExplosionFoundationsGeographic LocationsGoalsHealthHealth Insurance Portability and Accountability ActHealth PersonnelHealthcareIndividualIndustryInterventionInvestigationItalyJournalsLeadershipLinkLocationLocomotionMachine LearningManualsMeasuresMedicineModelingMonitorMorbidity - disease rateOpioidOutcomeParticipantPatientsPersonal SatisfactionPersonsPhysical activityPhysiologicalPhysiologyPopulationPost-Traumatic Stress DisordersPrecipitating FactorsPredispositionProviderPsychosocial FactorPublishingRandomized Controlled TrialsRecoveryRelapseResearchResearch PersonnelResearch Project GrantsResearch Project SummariesResourcesRoleSeizuresSensitivity and SpecificitySiteSkin TemperatureSleepSmall Business Innovation Research GrantSpecific qualifier valueStreamStressSubstance Use DisorderSubstance abuse problemSuicideSupport SystemSystemTechniquesTechnologyTextTimeUser ComplianceWireless TechnologyWristactive methodaddictionbasecloud basedcostcost effectivecravingdesigndigitalexperiencehandheld mobile devicehigh riskimprovedmobile applicationmortalitypersonalized medicinepreventpsychosocialrelapse risksensorservice providerssignal processingsmart watchsmartphone Applicationsobrietysoftware developmentstress managementstress reductionsubstance abuse treatmentsuccesstooltreatment programusabilitywearable devicewearable technology
项目摘要
PROJECT SUMMARY
The research project outlined in this SBIR submission will develop the Realize, Analyze, Engage (RAE)
platform into a tool to promote sustained recovery in individuals receiving treatment for substance use disorder.
In this proposal, the investigators intend to deploy the RAE system- consisting of a wearable sensor, a
smartphone app, and a clinical portal- to provide individuals in recovery and their treatment providers with an
opportunity to identify moments of high risk for relapse and to access real time intervention opportunities.
Wearable biosensors are small, noninvasive devices that continuously record physiology. These sensors have
the ability to detect digital biomarkers of drug use and stress, the latter of which herald an increased risk of
relapse. RAE aims to utilize this capability to create a real-time solution for individuals in recovery. The
components of RAE are: 1) The Empatica Embrace, a wrist mounted sensor similar in form factor to a smart
watch, that continuously monitors skin temperature, electrodermal activity (EDA) and locomotion. Detection
algorithms for stress and drug use will be embedded on the Embrace firmware. 2) The RAE smartphone
application (app), for the individual in recovery. The app will be triggered either by detection of an event on the
Embrace or manually by the user when needed and will provide multiple options for annotations, stress
reduction techniques and immediate contact with individuals in the pre-defined support system via call or SMS
text. The app will also log sleep, physical activity, and geographic location of events. 3) The RAE Portal, for
the treatment provider, will deliver immediate alerts when an event is detected on the user’s device for the
opportunity to intervene in real time and will also provide metrics on the user’s recorded activities. The
research plan has two Specific Aims: Aim 1) To deploy and optimize the RAE system in a population of
individuals in treatment for substance use disorder and Aim 2) To demonstrate the impact of the RAE system
on outcomes in substance use treatment. To achieve these aims the investigators will first deploy the
technology in a population of individuals in recovery and collect data on accuracy, usability and functionality
(Aim 1). The data from Aim 1 will be used to optimize the system and achieve millstones prior to transition to
Aim 2 which will include sensitivity, specify, accuracy and user compliance targets. The investigators will then
undertake a multi-site, randomized controlled trial (Aim 2) to evaluate the efficacy of RAE on key outcomes
including rates of relapse, retention in treatment programs, and psychosocial wellbeing. The investigators
have assembled a leadership team and advisory team with the necessary expertise in business, medicine,
wearable technology and engineering to develop RAE into a tool that dramatically improves the success of
treatment for substance use disorder, promotes sustained sobriety, and reduces morbidity and mortality from
relapse to substance use.
项目摘要
SBIR提交的研究项目将开发实现,分析,参与(RAE)
平台转化为工具,以促进接受药物使用障碍治疗的个人的持续康复。
在这项提案中,研究人员打算部署RAE系统-由可穿戴传感器,
智能手机应用程序和临床门户-为康复中的个人及其治疗提供者提供
有机会确定复发的高风险时刻,并获得真实的时间干预机会。
可穿戴生物传感器是一种小型、非侵入性的设备,可以连续记录生理状态。这些传感器具有
检测药物使用和压力的数字生物标志物的能力,后者预示着增加的风险,
复发RAE旨在利用这一能力为恢复中的个人创建实时解决方案。的
RAE的组成部分是:1)Empatica Embrace,一种手腕安装的传感器,外形与智能手机相似,
手表,持续监测皮肤温度,皮肤电活动(EDA)和运动。检测
压力和药物使用的算法将嵌入到Embrace固件中。2)RAE智能手机
应用程序(App),用于恢复中的个人。应用程序将通过检测到
拥抱或手动由用户在需要时,并将提供多种选项的注释,强调
减少技术和通过电话或短信与预定义支持系统中的个人立即联系
短信了该应用程序还将记录睡眠,身体活动和事件的地理位置。3)RAE门户网站,
当在用户设备上检测到事件时,治疗提供者将立即发出警报,
这将提供真实的时间干预的机会,并且还将提供关于用户的记录活动的度量。的
研究计划有两个具体目标:目标1)在人口中部署和优化RAE系统,
2)证明研究、咨询和教育系统的影响
药物使用治疗的结果。为了实现这些目标,调查人员将首先部署
技术在个人群体中恢复和收集关于准确性、可用性和功能性数据
(Aim 1)。目标1的数据将用于优化系统,并在过渡到
目标2包括敏感性、具体说明、准确性和用户依从性目标。调查人员将
进行多中心随机对照试验(目标2),以评估RAE对关键结局的疗效
包括复发率、治疗方案的保留率和心理社会健康。调查人员
已经组建了一个领导团队和咨询团队,他们在商业,医学,
可穿戴技术和工程开发RAE成为一种工具,大大提高了成功的
治疗物质使用障碍,促进持续清醒,并减少发病率和死亡率,
吸毒复发
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHANIE P CARREIRO其他文献
STEPHANIE P CARREIRO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHANIE P CARREIRO', 18)}}的其他基金
RAE cHealth: A digital community support tool to promote recovery from substance use disorder
RAE cHealth:促进药物滥用障碍康复的数字社区支持工具
- 批准号:
10838804 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
The ANTIDOTE Institute- Advancing New Toxicology Investigators in Drug abuse and Original Translational research Efforts
ANTIDOTE Institute - 推动新毒理学研究人员在药物滥用和原创转化研究工作中的发展
- 批准号:
10681927 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
MINDER: Wearable sensor-based detection of digital biomarkers of adherence to medications for opioid use disorder
MINDER:基于可穿戴传感器的数字生物标记检测,用于检测阿片类药物使用障碍药物的依从性
- 批准号:
10656796 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
RAE cHealth: A digital community support tool to promote recovery from substance use disorder
RAE cHealth:促进药物滥用障碍康复的数字社区支持工具
- 批准号:
10469897 - 财政年份:2022
- 资助金额:
$ 22.5万 - 项目类别:
iTransform: Wearable Biosensors to Detect the Evolution of Opioid Tolerance in Opioid Naïve Individuals
iTransform:可穿戴生物传感器检测阿片类药物耐受性的演变
- 批准号:
9889092 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders
RAE(实现、分析、参与)——一种基于数字生物标记的检测和干预系统,用于治疗药物滥用疾病恢复过程中的压力和渴望
- 批准号:
10356481 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders
RAE(实现、分析、参与)——一种基于数字生物标记的检测和干预系统,用于治疗药物滥用疾病恢复过程中的压力和渴望
- 批准号:
10370419 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:














{{item.name}}会员




